Top 50 Clinical Trial Platform - Series B

The startup operates a clinical trial data platform that integrates licensed healthcare professionals with connected technology to facilitate decentralized clinical trials. This approach enhances trial accessibility and efficiency, allowing patients to consult with doctors and enabling continuous patient monitoring outside traditional clinical settings.

Faro Health provides an AI-enabled platform for designing and implementing clinical trial protocols, streamlining the complexities of protocol development through data-driven insights and reusable content. This technology reduces authoring time and enhances the quality of clinical trials, minimizing patient burden and associated costs.

ObvioHealth offers the ObvioGo® 2.0 platform, which utilizes digital tools for real-time data capture and participant engagement in clinical trials. This technology addresses inefficiencies in traditional trial management by providing customizable study designs and enhancing data accuracy, resulting in faster recruitment and improved compliance.

Power Life Science is a platform that connects patients with over 30,000 active clinical trials, allowing them to filter options based on specific medical conditions, locations, and drug types. This service addresses the challenge of limited access to experimental treatments by streamlining the search process and facilitating direct connections with researchers.

Medrio provides a cloud‑based, no‑code platform that integrates electronic data capture, randomization and trial supply management, ePRO and eConsent into a single validated solution. The system enables sponsors and CROs to configure and launch studies in weeks, apply mid‑study amendments without downtime, and maintain real‑time, audit‑ready data across sites. Built‑in ISO 9001, GDPR and 21 CFR Part 11 compliance and 24/7 support help reduce operational costs and accelerate trial timelines.

Florence Healthcare provides a Site Enablement Platform that automates document workflows and participant enrollment for clinical trials, enhancing collaboration among sponsors, CROs, and research sites. By connecting over 20,000 research sites globally, the platform streamlines clinical research processes, reducing operational risks and accelerating trial timelines.

Lokavant provides a data-driven analytics platform that aggregates and integrates real-time data from various clinical trial sources. This technology enhances trial execution by enabling proactive management, operational health tracking, and risk-based monitoring, ultimately improving study efficiency and decision-making.

HealthMatch is a platform that connects patients with eligible clinical trials for new drugs and treatments by simplifying the search process and assessing trial eligibility. This service addresses the challenge of finding appropriate clinical studies, enabling patients to access potential therapies that may not be widely available.

Science 37 operates an FDA‑inspected direct‑to‑patient clinical trial site that enables sponsors to conduct all study visits, assessments, and data capture in participants’ homes through a network of certified research nurses. The platform integrates with sponsor eCRF systems, provides real‑time source‑verified data, and expands recruitment nationwide to improve patient diversity and accelerate enrollment timelines. It supports therapeutic‑area agnostic protocols while maintaining GCP compliance and remote monitoring.

Teckro provides a data-driven platform that enhances site engagement in clinical trials through real-time analytics and targeted interventions. By quantifying site performance, Teckro improves recruitment rates and accelerates study timelines, delivering measurable outcomes for pharmaceutical and biotech sponsors.

Topography Health provides a research platform that enables community physicians to conduct clinical trials, enhancing patient access to novel therapies while generating additional revenue for practices. By integrating tailored staffing services and advanced technology, the platform improves the quality, speed, and diversity of clinical research.

Mural Health offers Mural Link, a patient management platform that simplifies participation in clinical trials by providing flexible payment options, travel coordination, and real-time communication tools. This technology addresses high dropout rates and inefficient recruitment processes by enhancing participant engagement and streamlining operational workflows for study sponsors.

ConcertAI is an AI-driven platform that utilizes real-world data and advanced analytics to enhance clinical trial design and execution in oncology. The company addresses the inefficiencies in cancer research by providing biopharma partners with actionable insights to accelerate drug development and improve patient outcomes.

Datacubed Health provides a platform for electronic clinical outcomes assessments (eCOA) that enhances patient engagement through a mobile-friendly application designed for clinical trials. By utilizing behavioral science principles, the platform improves data collection accuracy and patient retention, addressing challenges in participant compliance and engagement across traditional, hybrid, and decentralized trial formats.

Curebase provides decentralized clinical research software that enables efficient data collection through electronic patient-reported outcomes (ePRO) and electronic consent (eConsent) systems. The platform enhances participant engagement and accelerates study launches while ensuring high-quality data capture across diverse clinical trials.

Pi Health offers the Front-end Interoperable Capture System (FICS), a software platform that integrates disparate applications to streamline data collection for clinical trials. This technology enhances site-sponsor connectivity, reduces operational inefficiencies, and accelerates patient access to innovative medicines and cancer care.

Inato has developed a global clinical trial marketplace that connects pharmaceutical sponsors with community-based research sites, enhancing patient access to clinical trials. By streamlining site selection and enrollment processes, Inato addresses the limited participation opportunities for diverse patient populations, ultimately accelerating the pace of medical research.

Beacon utilizes an EEG neurobiomarker platform powered by machine learning to enhance clinical trial efficiency and optimize treatment strategies for neurological and psychiatric disorders. By providing quantitative assessments of brain activity, the platform enables precise dose selection and patient stratification, improving the likelihood of successful treatment outcomes.

Lindus Health operates as an anti-CRO, utilizing a proprietary software platform and access to 30 million Electronic Health Records to execute end-to-end clinical trials with fixed pricing and milestone-based payments. By streamlining study design, patient recruitment, and data management, Lindus delivers trials up to three times faster than traditional CROs, ensuring timely access to new treatments for patients.

SubjectWell is a patient recruitment platform that utilizes machine learning to match healthcare-motivated patients with clinical studies across various therapeutic areas, ensuring a diverse and pre-qualified patient pool. By streamlining the connection between sponsors, CROs, and patients, SubjectWell reduces the time to start screening patients from weeks to days, enhancing the efficiency of clinical trials.

Zephyr AI utilizes an AI-enabled platform that integrates diverse healthcare and biological data to identify optimal patient-drug matches and enhance clinical trial efficiency. This approach addresses the challenges of patient stratification and drug development costs, ultimately improving patient outcomes through personalized therapies.

This startup develops AI-powered digital twins of patients to simulate drug effects and optimize clinical trials. Their platform uses machine learning to identify effective treatments for specific diseases, accelerating drug discovery and development.

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

The startup operates an integrated research organization that embeds clinical trials at the point of care, collaborating with healthcare providers to enhance patient participation and streamline data collection. This approach reduces the drug development timeline, improving access to clinical trials and outcomes for healthcare organizations.

Median Technologies offers the iCRO platform, an end‑to‑end imaging solution for oncology clinical trials that automates acquisition, de‑identification, storage and AI‑driven quantitative biomarker extraction from CT, MRI and PET scans to accelerate response assessment and regulatory reporting. The company also provides eyonis®, an AI/ML‑powered SaMD suite for computer‑assisted detection and diagnosis of early‑stage lung and liver cancers, delivering validated CADe/CADx performance through DICOM and HL7/FHIR integration. Both products are CE‑marked and FDA‑cleared, targeting pharma/biotech sponsors, CROs and radiology departments seeking scalable, compliant imaging analytics.

The startup is developing a Clinical Digital Twin Platform that creates virtual replicas of patients using real-time health data and advanced modeling techniques. This platform enables healthcare providers to personalize treatment plans and improve patient outcomes by simulating various clinical scenarios.

Sano Genetics provides a platform that integrates patient recruitment, DNA testing, and electronic medical record retrieval to enhance the efficiency of precision medicine studies. By automating workflows and facilitating participant engagement, Sano addresses the challenges of slow enrollment and data collection in clinical research.

Rune Labs develops a software platform that integrates with neuromodulation therapies to collect and analyze real-world data from patients with neurodegenerative diseases, particularly Parkinson's. This technology enables clinicians to access personalized patient data and supports life sciences companies in expediting therapy development through enhanced clinical trial processes.

Unlearn.ai develops machine-learning models that create digital twins of clinical trial participants, enabling the use of synthetic patient data to enhance control groups. This technology accelerates clinical trials by allowing smaller study designs while maintaining statistical power, ultimately reducing the time and cost associated with bringing new therapies to market.

Utilizes multimodal AI and behavioral signal processing to analyze vocal, visual, and physiological data for assessing mental and neurological health. This technology improves clinical trial reliability, reduces patient and staff burden through automated tracking and assessments, and enhances treatment outcomes by providing real-time, objective insights during and between clinical encounters.

Lightship utilizes inclusive technology and flexible visit options to enhance patient participation in clinical trials, removing geographic barriers and providing personalized support throughout the research process. This approach addresses the limited access and choice often faced by patients and providers, accelerating the development of new therapies for diverse populations.

Slope.io provides Biospecimen360™, a software solution for end-to-end biospecimen lifecycle management that captures sample metadata in real-time and coordinates logistics, processing, and tracking. The platform addresses inventory shortages and compliance issues in clinical trials, enabling faster decision-making and improved data quality for sponsors and research sites.

Empatica develops FDA-cleared wearable devices and a health monitoring platform that continuously collects clinical-quality health data and digital biomarkers from everyday life. This technology enables researchers and clinicians to monitor conditions such as epilepsy and movement disorders, enhancing data collection for clinical trials and real-world health insights.

Cumulus Neuroscience has developed a medical-grade platform that integrates at-home EEG monitoring with tablet-based cognitive assessments to collect longitudinal data on brain health. This technology addresses the challenges of late diagnosis and ineffective monitoring in neurodegenerative diseases and psychiatric disorders, facilitating more efficient clinical trials and improving therapy delivery.

4G Clinical offers Prancer RTSM®, a software solution for randomization and trial supply management that enhances clinical trial efficiency by allowing for flexible mid-study adjustments and minimizing supply waste. Their 4C Supply® tool helps clinical supply managers predict patient demand and assess supply chain risks, addressing the challenges of stock-outs and waste in increasingly complex trials.

MEDHINI is a generative AI-powered software platform that provides genomics-based multimodal solutions for healthcare diagnostics, focusing on areas such as antimicrobial resistance and virtual clinical trials. The platform enhances diagnostic accuracy and accessibility in pulmonology, neurology, nephrology, cardiology, and oncology, addressing the need for affordable healthcare solutions with measurable social impact.

Healthcare organizations often work with fragmented, incomplete, or outdated provider and patient data, which hampers efficient site selection for clinical trials, slows patient recruitment, and limits precise HCP engagement for medical affairs and commercial activities. Health plans also struggle with inaccurate provider directories, leading to network inefficiencies and suboptimal patient access. H1 delivers an integrated platform that combines software applications and curated data feeds to provide a single source of truth for clinicians, researchers, commercial teams, and payers.

N-Power Medicine embeds an always-on clinical research system into community oncology workflows via EHR integration, standardizing real-time data capture in the Kaleido Registry. This enables the creation of prospective external control cohorts for biopharma sponsors while accelerating patient enrollment and reducing documentation burden for physicians.

Medeloop utilizes deep AI model explainability techniques and a robust data linkage infrastructure to streamline clinical research by harmonizing and analyzing extensive health data. The platform enables researchers to generate hypotheses and publish findings more efficiently, ultimately accelerating the discovery of biomarkers for understudied diseases.

NeuraLight develops a software platform that utilizes computer vision and machine learning to analyze eye movements, providing objective measurements for central nervous system diseases. This technology enables researchers to differentiate between healthy subjects and patients, stratify subgroups, and monitor disease progression in clinical trials.

Beaconcure offers Verify, an automated solution utilizing machine learning and natural language processing for the validation of clinical trial statistical outputs. This technology enhances data accuracy and accelerates regulatory approval processes, enabling faster market entry for new drugs and vaccines.

Tasso supplies FDA‑cleared, at‑home blood collection devices that obtain 200‑600 µL of capillary whole blood or dried‑blood spots via a painless, vacuum‑driven lancet, compatible with standard microtainer tubes or proprietary cartridges. The company also provides an end‑to‑end logistics and data platform (Tasso Connect) with prepaid shipping, remote proctoring, and a secure API/dashboard for real‑time sample tracking and integration with laboratory or EHR systems, supporting decentralized clinical trials and remote monitoring.

Mendel is an AI platform that combines large language models with a clinical hypergraph to enable physician-level cognitive reasoning for analyzing structured and unstructured clinical data. It enhances clinical data workflows by providing accurate cohort retrieval and chart review, ensuring outputs are explainable and grounded in a coherent patient journey.

Nucleai has developed an AI-powered platform that utilizes military-grade geospatial analysis to interpret complex cellular interactions in biopsy samples, generating spatial biomarkers for precision medicine. This technology enhances drug development by providing actionable insights that improve patient selection for clinical trials and optimize treatment strategies.

Xenothera is a xenotherapy platform utilizing a glyco humanized antibody technology to enhance immunological treatments for various diseases. The platform aims to improve patient outcomes by providing more effective therapeutic options in clinical trials, including treatments for pancreatic cancer and peripheral T-cell lymphoma.

The startup develops clinically validated software applications that utilize artificial intelligence to analyze real-world data, enhancing patient outcomes and supporting the discovery of new medicines. By connecting patients, clinicians, and researchers, the platform generates extensive phenotypic databases that enable discovery research companies to maximize revenue in the healthcare sector.

Kyverna Therapeutics is developing CAR T-cell therapies to induce sustained treatment-free remission in patients with B cell-driven autoimmune diseases. Their clinical-stage platform includes autologous and allogeneic therapies currently undergoing trials for conditions such as lupus nephritis and multiple sclerosis.

Provides a federated data platform for healthcare organizations, enabling the integration and harmonization of structured and unstructured clinical data using NLP and OMOP CDM. This system supports real-world evidence generation and multicenter studies in oncology and cardiology, improving data quality and accelerating research while ensuring compliance with privacy regulations.

PatientIQ provides a platform that automates the collection and analysis of patient-reported outcomes data, integrating seamlessly with electronic health records (EHR) to enhance clinical decision-making. By enabling healthcare providers and researchers to leverage actionable insights from patient data, the platform improves patient care and supports clinical research initiatives.

VeriSIM Life utilizes an AI-driven computational bioplatform to predict clinical outcomes of drug candidates by integrating chemical and biological modeling with machine learning techniques. This approach addresses the inefficiencies and inaccuracies in drug development, enabling pharmaceutical companies to allocate resources more effectively and increase the likelihood of clinical success.